Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Mirum Pharmaceuticals stock

Learn how to easily invest in Mirum Pharmaceuticals stock.

Mirum Pharmaceuticals Inc is a biotechnology business based in the US. Mirum Pharmaceuticals shares (MIRM) are listed on the NASDAQ and all prices are listed in US Dollars. Mirum Pharmaceuticals employs 171 staff and has a trailing 12-month revenue of around $38.5 million.

How to buy shares in Mirum Pharmaceuticals

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – MIRM – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Mirum Pharmaceuticals stock price (NASDAQ: MIRM)

Use our graph to track the performance of MIRM stocks over time.

Mirum Pharmaceuticals shares at a glance

Information last updated 2022-10-03.
Latest market close$21.37
52-week range$12.82 - $30.55
50-day moving average $24.32
200-day moving average $22.27
Wall St. target price$57.71
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-2.29

Buy Mirum Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$0
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Public
Stocks, ETFs, Cryptocurrency
$0
$0
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Mirum Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Mirum Pharmaceuticals price performance over time

Historical closes compared with the close of $21.37 from 2022-10-04

1 week (2022-09-29) 1.81%
1 month (2022-09-06) -15.16%
3 months (2022-07-06) -1.75%
6 months (2022-04-05) -11.84%
1 year (2021-10-06) 22.60%
2 years (2020-10-06) 14.65%
3 years (2019-10-04) 103.72%
5 years (2017-10-02) N/A

Mirum Pharmaceuticals financials

Revenue TTM $38.5 million
Gross profit TTM $17.2 million
Return on assets TTM -35%
Return on equity TTM -51.44%
Profit margin -137.85%
Book value $3.39
Market capitalisation $772.2 million

TTM: trailing 12 months

Mirum Pharmaceuticals share dividends

We're not expecting Mirum Pharmaceuticals to pay a dividend over the next 12 months.

Mirum Pharmaceuticals share price volatility

Over the last 12 months, Mirum Pharmaceuticals's shares have ranged in value from as little as $12.82 up to $30.545. A popular way to gauge a stock's volatility is its "beta".

MIRM.US volatility(beta: 1.43)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Mirum Pharmaceuticals's is 1.4305. This would suggest that Mirum Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Mirum Pharmaceuticals overview

Mirum Pharmaceuticals, Inc. , a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of Alagille syndrome and biliary atresia disease. It also develops Volixibat drug for treatment of intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. Mirum Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Foster City, California. .

Frequently asked questions

What percentage of Mirum Pharmaceuticals is owned by insiders or institutions?
Currently 4.121% of Mirum Pharmaceuticals shares are held by insiders and 80.594% by institutions.
How many people work for Mirum Pharmaceuticals?
Latest data suggests 171 work at Mirum Pharmaceuticals.
When does the fiscal year end for Mirum Pharmaceuticals?
Mirum Pharmaceuticals's fiscal year ends in December.
Where is Mirum Pharmaceuticals based?
Mirum Pharmaceuticals's address is: 950 Tower Lane, Foster City, CA, United States, 94404
What is Mirum Pharmaceuticals's ISIN number?
Mirum Pharmaceuticals's international securities identification number is: US6047491013
What is Mirum Pharmaceuticals's CUSIP number?
Mirum Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 604749101

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site